Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 4

Status

Recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4

Conditions

Brain Neoplasms 10Glioblastoma 5Glioma 4Disease 2Recurrence 1Neoplasms 1

Interventions

Temozolomide 159Bevacizumab 69Radiotherapy 68Magnetic Resonance Spectroscopy 68Irinotecan 31Surgical Procedures, Operative 27Radiation 24Carboplatin 23Specimen Handling 20Carmustine 20Blood Specimen Collection 20Nivolumab 19Aminolevulinic Acid 18Biopsy 17Lomustine 15pembrolizumab 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13trametinib 12fluorodopa F 18 12X-Rays 12Radiosurgery 12Erlotinib Hydrochloride 12Topotecan 11Everolimus 11Magnetic Resonance Imaging 10IL13-PE38 10dabrafenib 9Etoposide 9Drug Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Glioma × fluciclovine F-18 × CNS × Clear all
NCT05555550 2026-04-29

Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG

Children's Hospital of Philadelphia

Phase EARLY_PHASE1 Recruiting
30 enrolled
CNS

Glioma

NCT05553041 2025-12-04

18F-Fluciclovine PET-MRI in High-grade Glioma

Children's Hospital of Philadelphia

Phase EARLY_PHASE1 Recruiting
30 enrolled
CNS

Glioma

NCT05054400 2023-09-01

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Withdrawn
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT04114370 2022-12-06

FACBC

University of Pittsburgh

Phase EARLY_PHASE1 Completed
9 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡